In contrast, others have reported decreased CBF in older APOE4 carriers relative to non-carriers [22], and that decreased CBF with aging may be more strongly associated with worsening cognition in APOE4 carriers relative to non-carriers, particularly in those with cognitive impairment [17, 22–24]. The gene discussed is APOE; the disease is Cognitive impairment.